MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers.

Phosphoinositides: tiny lipids with giant impact on cell regulation. Physiol Rev (2013) 3.21

Muscle pathology, limb strength, walking gait, respiratory function and neurological impairment establish disease progression in the p.N155K canine model of X-linked myotubular myopathy. Ann Transl Med (2015) 1.45

Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy. Sci Transl Med (2014) 1.32

Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy. Hum Mol Genet (2013) 1.09

Defective membrane remodeling in neuromuscular diseases: insights from animal models. PLoS Genet (2012) 1.05

Dominant mutation of CCDC78 in a unique congenital myopathy with prominent internal nuclei and atypical cores. Am J Hum Genet (2012) 1.04

Defects of Vps15 in skeletal muscles lead to autophagic vacuolar myopathy and lysosomal disease. EMBO Mol Med (2013) 1.04

Muscle function in a canine model of X-linked myotubular myopathy. Muscle Nerve (2012) 1.04

Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice. Am J Pathol (2011) 1.03

Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype. Hum Mol Genet (2011) 1.03

A frameshift mutation in golden retriever dogs with progressive retinal atrophy endorses SLC4A3 as a candidate gene for human retinal degenerations. PLoS One (2011) 1.03

Myotubularin-deficient myoblasts display increased apoptosis, delayed proliferation, and poor cell engraftment. Am J Pathol (2012) 0.96

Protein tyrosine phosphatase-like A regulates myoblast proliferation and differentiation through MyoG and the cell cycling signaling pathway. Mol Cell Biol (2011) 0.95

Pathogenic mechanisms in centronuclear myopathies. Front Aging Neurosci (2014) 0.94

Centronuclear myopathy in Labrador retrievers: a recent founder mutation in the PTPLA gene has rapidly disseminated worldwide. PLoS One (2012) 0.91

Skeletal Muscle Pathology in X-Linked Myotubular Myopathy: Review With Cross-Species Comparisons. J Neuropathol Exp Neurol (2016) 0.91

Altered splicing of the BIN1 muscle-specific exon in humans and dogs with highly progressive centronuclear myopathy. PLoS Genet (2013) 0.90

Reducing dynamin 2 expression rescues X-linked centronuclear myopathy. J Clin Invest (2014) 0.89

Gait characteristics in a canine model of X-linked myotubular myopathy. J Neurol Sci (2014) 0.87

Pathophysiological concepts in the congenital myopathies: blurring the boundaries, sharpening the focus. Brain (2014) 0.86

Clinical phenotype of X-linked myotubular myopathy in Labrador Retriever puppies. J Vet Intern Med (2015) 0.83

Annotation of the domestic dog genome sequence: finding the missing genes. Mamm Genome (2011) 0.83

Ultrasound assessment of the diaphragm: Preliminary study of a canine model of X-linked myotubular myopathy. Muscle Nerve (2014) 0.82

Validity of a Neurological Scoring System for Canine X-Linked Myotubular Myopathy. Hum Gene Ther Clin Dev (2015) 0.81

Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs. Mol Ther (2017) 0.81

A COLQ missense mutation in Labrador Retrievers having congenital myasthenic syndrome. PLoS One (2014) 0.81

Identification of putative SNPs in progressive retinal atrophy affected Canis lupus familiaris using exome sequencing. Mamm Genome (2015) 0.81

A novel mutation in TTC8 is associated with progressive retinal atrophy in the golden retriever. Canine Genet Epidemiol (2014) 0.80

Bridging integrator 1 (Bin1) deficiency in zebrafish results in centronuclear myopathy. Hum Mol Genet (2014) 0.80

Extensive morphological and immunohistochemical characterization in myotubular myopathy. Brain Behav (2013) 0.80

Adeno-associated virus-mediated gene therapy for metabolic myopathy. Hum Gene Ther (2013) 0.80

X-linked myotubular myopathy in Rottweiler dogs is caused by a missense mutation in Exon 11 of the MTM1 gene. Skelet Muscle (2015) 0.79

An Intronic SINE insertion in FAM161A that causes exon-skipping is associated with progressive retinal atrophy in Tibetan Spaniels and Tibetan Terriers. PLoS One (2014) 0.79

Gene therapy in myotubular myopathy: promising progress and future directions. Ann Transl Med (2015) 0.79

Gene therapy for inherited muscle diseases: where genetics meets rehabilitation medicine. Am J Phys Med Rehabil (2014) 0.78

X-linked recessive myotubular myopathy with MTM1 mutations. Korean J Pediatr (2013) 0.78

Canine muscle cell culture and consecutive patch-clamp measurements - a new approach to characterize muscular diseases in dogs. BMC Vet Res (2012) 0.77

Respiratory assessment in centronuclear myopathies. Muscle Nerve (2014) 0.77

Loss of catalytically inactive lipid phosphatase myotubularin-related protein 12 impairs myotubularin stability and promotes centronuclear myopathy in zebrafish. PLoS Genet (2013) 0.77

Gene replacement rescues severe muscle pathology and prolongs survival in myotubularin-deficient mice and dogs. Ann Transl Med (2015) 0.76

Gene therapy in monogenic congenital myopathies. Methods (2015) 0.76

Suspected congenital centronuclear myopathy in an Arabian-cross foal. J Vet Intern Med (2014) 0.76

In vivo imaging of skeletal muscle in mice highlights muscle defects in a model of myotubular myopathy. Intravital (2016) 0.75

Noninvasive Assessment of Neuromuscular Disease in Dogs: Use of the 6-minute Walk Test to Assess Submaximal Exercise Tolerance in Dogs with Centronuclear Myopathy. J Vet Intern Med (2016) 0.75

Long-term effects of systemic gene therapy in a canine model of myotubular myopathy. Muscle Nerve (2017) 0.75

Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature (2006) 5.83

A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet (1996) 3.67

Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer (2008) 3.23

Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs. Ann Neurol (2009) 3.01

The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature (1988) 2.75

An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. Genomics (1992) 2.29

Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy. PLoS Genet (2009) 2.23

Myotubularin phosphatases: policing 3-phosphoinositides. Trends Cell Biol (2006) 2.09

The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice. Proc Natl Acad Sci U S A (2002) 1.91

"Necklace" fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy. Acta Neuropathol (2008) 1.83

T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase. Proc Natl Acad Sci U S A (2009) 1.83

Medical complications in long-term survivors with X-linked myotubular myopathy. J Pediatr (1999) 1.74

SINE exonic insertion in the PTPLA gene leads to multiple splicing defects and segregates with the autosomal recessive centronuclear myopathy in dogs. Hum Mol Genet (2005) 1.65

Endosomal phosphoinositides and human diseases. Traffic (2008) 1.64

X-linked myotubular and centronuclear myopathies. J Neuropathol Exp Neurol (2005) 1.61

Characterization of MTMR3. an inositol lipid 3-phosphatase with novel substrate specificity. Curr Biol (2001) 1.55

AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis. Hum Mol Genet (2008) 1.44

Characterisation of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype. Hum Genet (2002) 1.41

The PtdIns3P phosphatase myotubularin is a cytoplasmic protein that also localizes to Rac1-inducible plasma membrane ruffles. J Cell Sci (2002) 1.29

Canine X-linked muscular dystrophy in Japan (CXMDJ). Exp Anim (2003) 1.27

Diagnosis of X-linked myotubular myopathy by detection of myotubularin. Ann Neurol (2001) 1.11

Hereditary myopathy in Labrador retrievers: a morphologic study. Vet Pathol (1986) 1.04

Myofiber size correlates with MTM1 mutation type and outcome in X-linked myotubular myopathy. Neuromuscul Disord (2007) 1.03

A muscle disorder of Labrador retrievers characterized by deficiency of type II muscle fibers. J Am Vet Med Assoc (1976) 1.00

X-linked myotubular myopathy in a family with three adult survivors. Clin Genet (2003) 1.00

A possible new inherited myopathy in a young Labrador retriever. Can Vet J (2008) 0.97

Expression of fiber type specific proteins during ontogeny of canine temporalis muscle. Muscle Nerve (1988) 0.81

Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature (2005) 23.04

Dynamics of mammalian chromosome evolution inferred from multispecies comparative maps. Science (2005) 5.47

Centronuclear (myotubular) myopathy. Orphanet J Rare Dis (2008) 2.53

Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy. Nat Genet (2007) 2.48

Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet (2005) 2.33

A 1-Mb resolution radiation hybrid map of the canine genome. Proc Natl Acad Sci U S A (2003) 2.30

Identification of genomic regions associated with phenotypic variation between dog breeds using selection mapping. PLoS Genet (2011) 2.24

SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes. Nat Med (2007) 2.17

Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy. Neurology (2013) 2.09

Control of autophagy initiation by phosphoinositide 3-phosphatase Jumpy. EMBO J (2009) 2.07

The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice. Proc Natl Acad Sci U S A (2002) 1.91

BAG3 deficiency results in fulminant myopathy and early lethality. Am J Pathol (2006) 1.90

Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy. Nat Med (2011) 1.87

T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase. Proc Natl Acad Sci U S A (2009) 1.83

Myotubularin regulates the function of the late endosome through the gram domain-phosphatidylinositol 3,5-bisphosphate interaction. J Biol Chem (2004) 1.73

Mutations in DMRT3 affect locomotion in horses and spinal circuit function in mice. Nature (2012) 1.72

Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (2009) 1.72

A high density SNP array for the domestic horse and extant Perissodactyla: utility for association mapping, genetic diversity, and phylogeny studies. PLoS Genet (2012) 1.66

The phosphoinositide kinase PIKfyve/Fab1p regulates terminal lysosome maturation in Caenorhabditis elegans. Mol Biol Cell (2006) 1.66

A mutation in the canine BHD gene is associated with hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis in the German Shepherd dog. Hum Mol Genet (2003) 1.66

SINE exonic insertion in the PTPLA gene leads to multiple splicing defects and segregates with the autosomal recessive centronuclear myopathy in dogs. Hum Mol Genet (2005) 1.65

Endosomal phosphoinositides and human diseases. Traffic (2008) 1.64

An integrated 4249 marker FISH/RH map of the canine genome. BMC Genomics (2004) 1.61

Production of phosphatidylinositol 5-phosphate by the phosphoinositide 3-phosphatase myotubularin in mammalian cells. J Biol Chem (2003) 1.58

PNPLA1 mutations cause autosomal recessive congenital ichthyosis in golden retriever dogs and humans. Nat Genet (2012) 1.55

Hereditary myopathy with early respiratory failure: occurrence in various populations. J Neurol Neurosurg Psychiatry (2013) 1.52

Genotype-phenotype correlations in X-linked myotubular myopathy. Neuromuscul Disord (2002) 1.51

Reduced transcript expression of genes affected by inherited and de novo CNVs in autism. Eur J Hum Genet (2011) 1.48

Nesprin 1 is critical for nuclear positioning and anchorage. Hum Mol Genet (2009) 1.48

Sequential actions of myotubularin lipid phosphatases regulate endosomal PI(3)P and growth factor receptor trafficking. Mol Biol Cell (2008) 1.48

Inherited motor neuron disease in domestic cats: a model of spinal muscular atrophy. Pediatr Res (2005) 1.46

Testosterone replacement therapy and motor function in men with spinal cord injury: a retrospective analysis. Am J Phys Med Rehabil (2008) 1.43

Characterisation of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype. Hum Genet (2002) 1.41

Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch. Pain (2004) 1.40

Expanded repeat in canine epilepsy. Science (2005) 1.37

Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies. Acta Neuropathol (2010) 1.34

Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells. Hum Mol Genet (2002) 1.33

A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy. Hum Mol Genet (2006) 1.33

Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy. Sci Transl Med (2014) 1.32

Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocin-diabetic mice. Neurosci Lett (2008) 1.31

Myotubularin lipid phosphatase binds the hVPS15/hVPS34 lipid kinase complex on endosomes. Traffic (2007) 1.29

Myotubularin phosphoinositide phosphatases: cellular functions and disease pathophysiology. Trends Mol Med (2012) 1.29

Canine population structure: assessment and impact of intra-breed stratification on SNP-based association studies. PLoS One (2007) 1.29

Epidermal nerve fiber quantification in the assessment of diabetic neuropathy. Acta Histochem (2008) 1.29

AutoGRAPH: an interactive web server for automating and visualizing comparative genome maps. Bioinformatics (2006) 1.28

Comparison of the canine and human olfactory receptor gene repertoires. Genome Biol (2003) 1.28

Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies. Mamm Genome (2012) 1.28

Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord (2007) 1.28

Genome-wide analysis reveals selection for important traits in domestic horse breeds. PLoS Genet (2013) 1.26

The first radiation hybrid map of a perch-like fish: the gilthead seabream (Sparus aurata L). Genomics (2006) 1.26

Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy. Hum Mutat (2012) 1.25

T-tubule biogenesis and triad formation in skeletal muscle and implication in human diseases. Skelet Muscle (2011) 1.22

Myotubularin controls desmin intermediate filament architecture and mitochondrial dynamics in human and mouse skeletal muscle. J Clin Invest (2010) 1.21

CXorf6 is a causative gene for hypospadias. Nat Genet (2006) 1.21

Constitutive activation of the calcium sensor STIM1 causes tubular-aggregate myopathy. Am J Hum Genet (2013) 1.20

Identification of myotubularin as the lipid phosphatase catalytic subunit associated with the 3-phosphatase adapter protein, 3-PAP. Proc Natl Acad Sci U S A (2003) 1.19

Genetic diversity in the modern horse illustrated from genome-wide SNP data. PLoS One (2013) 1.18

The MMP-9/TIMP-1 axis controls the status of differentiation and function of myelin-forming Schwann cells in nerve regeneration. PLoS One (2012) 1.18

PtdIns5P regulation through evolution: roles in membrane trafficking? Trends Biochem Sci (2008) 1.17

Construction of a 2-Mb resolution BAC microarray for CGH analysis of canine tumors. Genome Res (2005) 1.16

LUPA: a European initiative taking advantage of the canine genome architecture for unravelling complex disorders in both human and dogs. Vet J (2011) 1.15

Expression of myotubularin by an adenoviral vector demonstrates its function as a phosphatidylinositol 3-phosphate [PtdIns(3)P] phosphatase in muscle cell lines: involvement of PtdIns(3)P in insulin-stimulated glucose transport. Mol Endocrinol (2003) 1.15

Elimination of myostatin does not combat muscular dystrophy in dy mice but increases postnatal lethality. Am J Pathol (2005) 1.15

Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy. J Clin Invest (2003) 1.14

Increased expression of wild-type or a centronuclear myopathy mutant of dynamin 2 in skeletal muscle of adult mice leads to structural defects and muscle weakness. Am J Pathol (2011) 1.13

Kinematics of gait in golden retriever muscular dystrophy. Neuromuscul Disord (2009) 1.13

Characterization and in vivo functional analysis of splice variants of cypher. J Biol Chem (2002) 1.13

A high-resolution map of the Nile tilapia genome: a resource for studying cichlids and other percomorphs. BMC Genomics (2012) 1.12

Anemia in cats with hemotropic mycoplasma infection: retrospective evaluation of 23 cases (1996-2005). Can Vet J (2009) 1.11

Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy. Hum Mol Genet (2013) 1.09

Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma. Arch Ophthalmol (2006) 1.08

Mastermind-like domain-containing 1 (MAMLD1 or CXorf6) transactivates the Hes3 promoter, augments testosterone production, and contains the SF1 target sequence. J Biol Chem (2007) 1.08

Novel origins of copy number variation in the dog genome. Genome Biol (2012) 1.06

Effects of prednisone in canine muscular dystrophy. Muscle Nerve (2004) 1.06

Loss of modifier of cell adhesion reveals a pathway leading to axonal degeneration. J Neurosci (2009) 1.06

Vici syndrome associated with sensorineural hearing loss and evidence of neuromuscular involvement on muscle biopsy. Am J Med Genet A (2010) 1.06

Mutation update: the spectra of nebulin variants and associated myopathies. Hum Mutat (2014) 1.06

The paradox of muscle hypertrophy in muscular dystrophy. Phys Med Rehabil Clin N Am (2012) 1.06

Glycogen synthase (GYS1) mutation causes a novel skeletal muscle glycogenosis. Genomics (2008) 1.06

Defective membrane remodeling in neuromuscular diseases: insights from animal models. PLoS Genet (2012) 1.05

Comparable myelinated nerve pathology in feline and human diabetes mellitus. Acta Neuropathol (2007) 1.05

The ER-bound RING finger protein 5 (RNF5/RMA1) causes degenerative myopathy in transgenic mice and is deregulated in inclusion body myositis. PLoS One (2008) 1.05

Repeated monitoring of corneal nerves by confocal microscopy as an index of peripheral neuropathy in type-1 diabetic rodents and the effects of topical insulin. J Peripher Nerv Syst (2013) 1.04

Muscle histopathology in nebulin-related nemaline myopathy: ultrastrastructural findings correlated to disease severity and genotype. Acta Neuropathol Commun (2014) 1.04

Muscle function in a canine model of X-linked myotubular myopathy. Muscle Nerve (2012) 1.04

A canine DNM1 mutation is highly associated with the syndrome of exercise-induced collapse. Nat Genet (2008) 1.03

Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice. Am J Pathol (2011) 1.03

Next generation sequencing for molecular diagnosis of neuromuscular diseases. Acta Neuropathol (2012) 1.03